Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 10/16/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ronald Alvarez MD, MBA | Inovia | Eisai Inc. Genentech, Inc. TESARO, Inc. Unleash |
None | None | ✔ |
| Deborah Armstrong MD | AstraZeneca Pharmaceuticals LP Clovis Oncology Eisai Inc. Pfizer Inc. Syndax TESARO, Inc. |
AbbVie, Inc. CUE biopharma Eisai Inc. |
None | None | ✔ |
| Jamie Bakkum-Gamez MD | Exact Sciences | None | None | None | - |
| Lisa Barroilhet MD | None | None | None | None | - |
| Kian Behbakht MD | None | AstraZeneca Pharmaceuticals LP Clovis Oncology |
None | None | ✔ |
| Andrew Berchuck MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Lee-May Chen MD | None | None | None | None | ✔ |
| Mihaela Cristea MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP |
None | None | None | - |
| Marie DeRosa RN | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Eric Eisenhauer MD | None | None | None | None | ✔ |
| Anita Engh PhD | None | None | None | None | ✔ |
| David Gershenson MD | National Cancer Institute Novartis Pharmaceuticals Corporation |
Genentech, Inc. | National Cancer Institute | Biogen Idec|Bristol-Myers Squibb Company|Elsevier|Johnson & Johnson|UpToDate | ✔ |
| Heidi Gray MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | ✔ |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Angela Jain MD | None | None | None | None | ✔ |
| Amer Karam MD | Cardinal Health | Clovis Oncology | AstraZeneca Pharmaceuticals LP Clovis Oncology GlaxoSmithKline |
None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Gottfried Konecny MD | Eli Lilly and Company Merck & Co., Inc. |
None | AstraZeneca Pharmaceuticals LP Clovis Oncology TESARO, Inc. |
None | ✔ |
| Charles Leath III MD, MSPH | Celsion PAREXEL International Corporation |
AbbVie, Inc. Clovis Oncology Eisai Inc. GlaxoSmithKline Seattle Genetics, Inc. |
None | None | ✔ |
| Joyce Liu MD, MPH | 2X Oncology Aravive Arch Oncology AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Clovis Oncology CytoMX Therapeutics GlaxoSmithKline Regeneron Pharmaceuticals, Inc. TESARO, Inc. Vigeo Therapeutics |
AstraZeneca Pharmaceuticals LP Genentech, Inc. GlaxoSmithKline Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Daniel Lui PharmD, BCPPS | None | None | Brand Institute Inc MedPanel MNOW (Sermo) Reckner |
None | ✔ |
| Haider Mahdi MD, MPH | Puma Biotechnology | None | None | None | ✔ |
| Lainie Martin MD | Agenus Inc. AstraZeneca Pharmaceuticals LP SUTRO Biopharma, Inc. |
Elucida SUTRO Biopharma, Inc. |
AstraZeneca Pharmaceuticals LP GlaxoSmithKline ImmunoGen, Inc. |
None | ✔ |
| Daniela Matei MD | AbbVie, Inc. Astex Pharmaceuticals Ipsen Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Clovis Oncology GlaxoSmithKline Gynecologic Oncology Foundation |
None | None | ✔ |
| Michael McHale MD | Versatem : stage IB/II Trial | Bristol-Myers Squibb Company GlaxoSmithKline |
TESARO, Inc. | None | ✔ |
| Karen McLean MD, PhD | None | None | None | None | ✔ |
| David Miller MD, FACOG, FACS | ADVAXIS INC ADVENCHEN LABORATORIES LLC Aeterna Zentaris Agenus Inc. Aprea AB ImmunoGen, Inc. Karyopharm Therapeutics MATEON THERAPEUTICS Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NOVELLA CLINICAL nVISION MEDICAL CORPORATION Pfizer Inc. Regeneron Pharmaceuticals, Inc. Syros Pharmaceuticals TRACON Pharmaceuticals, Inc. US BIOTEST INC |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Asymmetric Therapeutics, LLC Boston Biomedical Curio Science LLC Eisai Inc. GlaxoSmithKline Karyopharm Therapeutics Myriad Genetic Laboratories, Inc. Tarveda Therapeutics TESARO, Inc. |
None | None | ✔ |
| David O'Malley MD | AbbVie, Inc. Agenus Ajinomoto Inc Amgen Inc. Array AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company CERULEAN PHARMA Clovis Oncology Eisai Inc. EMD Serono ErgoMed Genentech, Inc. GenMab GlaxoSmithKline GOG Foundation ImmunoGen, Inc. INC Research, Inc Iovance Biotherapeutics, Inc Janssen Pharmaceutica Products, LP Marker Therapeutics Merck & Co., Inc. Novocure PRA Intl Seattle Genetics, Inc. Serono Inc, Stemcentrx TESARO, Inc. TRACON Pharmaceuticals, Inc. |
Agenus Ambry AstraZeneca Pharmaceuticals LP Eisai Inc. Genentech, Inc. GlaxoSmithKline ImmunoGen, Inc. Mersana Regeneron Pharmaceuticals, Inc. |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | ✔ |
| Sanja Percac-Lima MD, PhD | None | None | None | None | ✔ |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Elena Ratner MD | Covidien AG | Genentech, Inc. guidepoint consulting Legal expert witness TESARO, Inc. |
Zai labs | None | - |
| Leslie Ray PharmD | None | None | None | None | ✔ |
| Steven Remmenga MD | None | None | None | None | ✔ |
| Paul Sabbatini MD | Bristol-Myers Squibb Company | None | None | None | - |
| Bettyanne Sunderland BSN, RN, OCN | None | None | None | None | ✔ |
| Erin Vidic | None | None | None | None | ✔ |
| Theresa Werner MD | None | None | None | None | ✔ |
| Emese Zsiros MD, PhD | None | Iovance | None | None | ✔ |